RAPH News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-07-17 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 5.02. |
| 2026-03-24 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 5.02. |
| 2025-08-11 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 8.01. |
| 2025-08-11 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 5.02. |
| 2025-01-14 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 5.02. |
| 2024-12-30 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 8.01. |
| 2024-09-11 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 4.01,9.01. |
| 2024-06-26 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 5.03,9.01. |
| 2024-05-02 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 8.01. |
| 2023-03-28 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 8.01. |
| 2023-01-26 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K/A | Raphael Pharmaceutical Inc. filed Form 8-K/A covering items 5.02,9.01. |
| 2022-10-24 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 8.01. |
| 2022-07-07 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 4.01,5.02,9.01. |
| 2013-05-29 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 4.01,9.01. |
| 2010-10-05 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 3.02,5.02. |
| 2010-08-25 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 5.02. |
| 2010-01-20 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 4.01,9.01. |
| 2009-09-10 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K/A | Raphael Pharmaceutical Inc. filed Form 8-K/A covering items 4.01,9.01. |
| 2009-09-04 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 8.01. |
| 2009-08-06 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 4.01,9.01. |
| 2008-07-07 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K/A | Raphael Pharmaceutical Inc. filed Form 8-K/A covering items 9.01. |
| 2008-04-03 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 3.02. |
| 2008-03-24 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 1.01,9.01. |
| 2008-02-13 | Current report | SEC filing | Raphael Pharmaceutical Inc. filed Form 8-K | Raphael Pharmaceutical Inc. filed Form 8-K covering items 3.03,5.03,9.01. |